2 highly rated blue chip ASX 200 shares

There are many blue chip options for investors on the ASX. Are these among the best?

| More on:
asx blue chip shares represented by pile of blue casino chips in front of bar graph

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

Given the large number of blue chip shares out there for investors to choose from, it can be hard to decide which ones to buy.

In order to narrow things down for you, I have picked out two blue chip shares which come highly rated right now. They are as follows:

CSL Limited (ASX: CSL)

The first blue chip share to look at is CSL. It is one of the world's leading biotechnology companies with a portfolio of leading therapies and vaccines. This includes flu vaccines, immunoglobulins, and countless other plasma-based products.

However, the company isn't settling for that and continues to invest heavily in its research and development (R&D). In fact, each year, the company invests somewhere in the region of 11% of its sales back into R&D activities. This means that approximately US$1 billion will be spent this year to ensure that the company's R&D pipeline is filled to the brim with innovative and potentially lucrative products.

One leading broker that is positive on the company is Citi. Its analysts currently have a buy rating and $310.00 price target on its shares.

Sonic Healthcare Limited (ASX: SHL)

Another blue chip ASX 200 share to consider is Sonic Healthcare. It is a leading medical diagnostics company which has been growing at a very strong rate in FY 2021.

For example, during the first half, the company delivered a 33% increase in revenue to $4.4 billion and a 166% jump in first half net profit to $678 million. A key driver of this growth was strong demand for COVID-19 testing services, which was supported by positive performances from the rest of the business.

And with COVID-19 testing expected to remain strong for a little while to come, Sonic looks set to continue its growth in FY 2022. In addition to this, due to its strong balance sheet, the company has the optionality to boost its growth through earnings accretive acquisitions.

One broker that is particularly positive on the company is Credit Suisse. It has an outperform rating and $40.00 price target on the company's shares.

James Mickleboro does not own any shares mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended CSL Ltd. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Blue Chip Shares

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Blue Chip Shares

2 ASX stocks to hold for steady gains

Analysts think these stocks could deliver the goods for investors.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Blue Chip Shares

The best ASX 200 blue chip shares to buy now with $3,000

Let's see why analysts think these are among the best stocks to buy right now.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Blue Chip Shares

Are these ASX 200 blue-chip shares undervalued?

Could now be time to jump in on these struggling blue chip holdings?

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Blue Chip Shares

The best blue chip ASX 200 shares to buy this month

Let's see which blue chips are best buys according to analysts at Bell Potter.

Read more »

Blue chips with stock written on them.
Blue Chip Shares

Why these ASX blue-chip shares are top buys for this fund manager

Here are two of the most appealing ASX blue-chip shares.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Blue Chip Shares

3 high-conviction ASX 200 shares I'd buy in June

Let's see why these strong stocks could be top picks for investors this month.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Blue Chip Shares

Morgans says these ASX 200 blue chip shares are buys

Let's see which blue chips the broker is recommending to clients.

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Blue Chip Shares

3 super strong ASX 200 blue chip shares to buy now

These blue chips have been given a big thumbs up by brokers.

Read more »